KRYS

KRYS

USD

Krystal Biotech Inc. Common Stock

$203.260+7.795 (3.988%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$195.465

Hoch

$212.980

Tief

$195.465

Volumen

0.66M

Unternehmensfundamentaldaten

Marktkapitalisierung

5.9B

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.32M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $122.8Aktuell $203.260Hoch $212.98

Ähnliche Nachrichten

Analyst Upgrades

Citigroup Maintains Neutral on Krystal Biotech, Raises Price Target to $198

Citigroup analyst Yigal Nochomovitz maintains Krystal Biotech with a Neutral and raises the price target from $166 to $198.

Mehr anzeigen
Citigroup Maintains Neutral on Krystal Biotech, Raises Price Target to $198
Analyst Upgrades

Chardan Capital Maintains Buy on Krystal Biotech, Raises Price Target to $220

Chardan Capital analyst Geulah Livshits maintains Krystal Biotech with a Buy and raises the price target from $216 to $220.

Mehr anzeigen
Chardan Capital Maintains Buy on Krystal Biotech, Raises Price Target to $220
GlobeNewswire

Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results

$97.8 million in 3Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in 4Q Updated U.S. VYJUVEK label expands eligible patient population and

Mehr anzeigen
Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results